Quick Answer
FENNEC PHARMACEUTICALS INC. reported Total Assets of $70.55 million for the year ending 2025.
- FENNEC PHARMACEUTICALS INC. showed an increase of +57.0% in Total Assets from 2024 to 2025.
- This data is from FENNEC PHARMACEUTICALS INC.'s annual report (Form 10-K), filed with the SEC on March 27, 2026.
- XBRL data for this metric is available from 2010 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2011: $6.83 million | Q3 2011: $6.27 million | Q1 2012: $4.76 million | Q2 2012: $3.60 million | Q3 2012: $2.93 million | Q1 2013: $1.94 million | Q2 2013: $1.03 million | Q3 2013: $640.0 thousand | Q1 2014: $1.40 million | Q2 2014: $1.05 million | Q3 2014: $673.0 thousand | Q1 2015: $1.95 million | Q2 2015: $1.87 million | Q3 2015: $1.45 million | Q1 2016: $588.0 thousand | Q2 2016: $5.10 million | Q3 2016: $4.58 million | Q1 2017: $3.29 million | Q2 2017: $10.26 million | Q3 2017: $9.89 million | Q1 2018: $26.84 million | Q2 2018: $25.70 million | Q1 2019: $20.66 million | Q2 2019: $17.83 million | Q3 2019: $15.91 million | Q1 2020: $10.37 million | Q2 2020: $39.32 million | Q3 2020: $34.07 million | Q1 2021: $27.83 million | Q2 2021: $28.12 million | Q3 2021: $26.01 million | Q1 2022: $19.15 million | Q2 2022: $15.57 million | Q3 2022: $30.42 million | Q1 2023: $21.82 million | Q2 2023: $19.44 million | Q1 2024: $69.19 million | Q2 2024: $63.16 million | Q3 2024: $58.92 million | Q1 2025: $46.40 million | Q2 2025: $44.88 million | Q3 2025: $49.26 million.
- Over the full 17 years of available data (2010 to 2025), FENNEC PHARMACEUTICALS INC.'s Total Assets has grown by 1,077.2%.
- Historical annual values: Fiscal year 2025: $70.55 million | Fiscal year 2024: $44.95 million | Fiscal year 2023: $26.86 million | Fiscal year 2023: $19.98 million | Fiscal year 2022: $26.94 million | Fiscal year 2021: $22.41 million | Fiscal year 2020: $31.42 million | Fiscal year 2019: $14.15 million | Fiscal year 2018: $22.95 million | Fiscal year 2017: $28.40 million | Fiscal year 2016: $3.97 million | Fiscal year 2015: $1.02 million | Fiscal year 2014: $2.37 million | Fiscal year 2013: $1.75 million | Fiscal year 2012: $2.37 million | Fiscal year 2011: $5.35 million | Fiscal year 2010: $5.99 million.
- Data sourced from SEC EDGAR public filings as of August 4, 2026.
Last verified: